Literature DB >> 1530912

Down syndrome (DS) peripheral blood contains phenotypically mature CD3+TCR alpha, beta+ cells but abnormal proportions of TCR alpha, beta+, TCR gamma, delta+, and CD4+ CD45RA+ cells: evidence for an inefficient release of mature T cells by the DS thymus.

M Murphy1, L B Epstein.   

Abstract

Down syndrome (DS) thymocytes have a markedly diminished proportion of cells expressing high levels of the alpha, beta T cell receptor (TCR alpha, beta) and the associated CD3 molecule. Thus, we examined the surface expression of TCR alpha, beta and CD3 as well as TCR gamma, delta, CD4, CD8, CD16, and CD45RA on peripheral blood lymphocytes (PBL) from 13 noninstitutionalized subjects with DS and 13 closely age-matched sibling controls using immunofluorescence and flow cytometry. DS PBL expressed high surface levels of TCR alpha, beta and CD3, but, as compared to controls, they had a lower proportion of cells expressing TCR alpha, beta (61% vs. 68%, respectively; P less than or equal to 0.05). Moreover, the absolute number of TCR alpha, beta+ cells was considerably lower for DS subjects than for controls (1634 +/- 229 vs. 2763 +/- 530, respectively; P less than or equal to 0.05). DS subjects had a markedly higher proportion of cells expressing TCR gamma, delta than did the controls (12% vs. 7%, respectively; P less than or equal to 0.02). In addition, DS subjects had a lower proportion of CD4+CD45RA+ cells than controls (22% vs. 35%, respectively; P less than or equal to 0.02), representing naive T cells which have recently emigrated from the thymus. The imbalance in the proportions of T cell subpopulations we have observed in DS PBL may contribute to the increased susceptibility to infection associated with DS and may represent a diminished efficiency in the production of newly differentiated T cells by the DS thymus.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1530912     DOI: 10.1016/0090-1229(92)90079-4

Source DB:  PubMed          Journal:  Clin Immunol Immunopathol        ISSN: 0090-1229


  13 in total

1.  Defective thymic progenitor development and mature T-cell responses in a mouse model for Down syndrome.

Authors:  Laureanne P E Lorenzo; Kristen E Shatynski; Sarah Clark; Paul J Yarowsky; Mark S Williams
Journal:  Immunology       Date:  2013-08       Impact factor: 7.397

2.  Tumorigenesis in Down's syndrome: big lessons from a small chromosome.

Authors:  Dean Nižetić; Jürgen Groet
Journal:  Nat Rev Cancer       Date:  2012-09-21       Impact factor: 60.716

3.  Serum levels of gamma interferon in patients with Down's syndrome.

Authors:  D Torre; M Broggini; C Zeroli; L Agrifoglio; V Bottà; R Casalone; G Ferrario
Journal:  Infection       Date:  1995 Jan-Feb       Impact factor: 3.553

Review 4.  Infections and immunodeficiency in Down syndrome.

Authors:  G Ram; J Chinen
Journal:  Clin Exp Immunol       Date:  2011-02-24       Impact factor: 4.330

5.  Lack of age-associated LFA-1 up-regulation and impaired ICAM-1 binding in lymphocytes from patients with Down syndrome.

Authors:  S J Lin; J Y Wang; L B Klickstein; K P Chuang; J Y Chen; J F Lee; C C Shieh
Journal:  Clin Exp Immunol       Date:  2001-10       Impact factor: 4.330

6.  Adults with Trisomy 21 Have Differential Antibody Responses to Influenza A.

Authors:  Stephanie James; Robert C Haight; Cassandra Hanna; Lindsey Furton
Journal:  Vaccines (Basel)       Date:  2022-07-19

Review 7.  Intrinsic defect of the immune system in children with Down syndrome: a review.

Authors:  M A A Kusters; R H J Verstegen; E F A Gemen; E de Vries
Journal:  Clin Exp Immunol       Date:  2009-01-22       Impact factor: 4.330

8.  Shigella infection induces cellular activation of T and B cells and distinct species-related changes in peripheral blood lymphocyte subsets during the course of the disease.

Authors:  D Islam; P K Bardhan; A A Lindberg; B Christensson
Journal:  Infect Immun       Date:  1995-08       Impact factor: 3.441

9.  Maturation-dependent licensing of naive T cells for rapid TNF production.

Authors:  Bhavana Priyadharshini; Raymond M Welsh; Dale L Greiner; Rachel M Gerstein; Michael A Brehm
Journal:  PLoS One       Date:  2010-11-24       Impact factor: 3.240

10.  Thymic abnormalities and enhanced apoptosis of thymocytes and bone marrow cells in transgenic mice overexpressing Cu/Zn-superoxide dismutase: implications for Down syndrome.

Authors:  M Peled-Kamar; J Lotem; E Okon; L Sachs; Y Groner
Journal:  EMBO J       Date:  1995-10-16       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.